摘要
目的探讨伸筋草生物碱对完全弗氏佐剂(CFA)诱导大鼠关节炎的治疗作用及机制。方法健康SD大鼠48只,随机分为6组,每组8只,即对照组、模型组、依托考昔片(阳性药,1 mg/kg)组及伸筋草生物碱低、中、高剂量(30、60、120 mg/kg)组,除对照组外,其余40只大鼠sc 0.1 mL CFA造模,致炎15 d后,连续ig给药30 d。测定大鼠足趾肿胀率、HE染色后观察造模测踝关节滑膜病理改变;致炎45 d,ELISA法测定血清中白介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)水平。结果与模型组比较,依托考昔片及伸筋草生物碱低、中、高剂量组足趾肿胀率均显著下降(P<0.05、0.01);中、高剂量伸筋草生物碱明显改善滑膜细胞、巨噬细胞、纤维细胞增生与炎症细胞浸润;与模型组比较,依托考昔片及伸筋草生物碱高剂量组大鼠血清TNF-α水平显著下降(P<0.05),依托考昔片及伸筋草生物碱各剂量组IL-1β水平均显著降低(P<0.01)。结论伸筋草生物碱显著抑制CFA诱导关节炎大鼠关节肿胀,改善大鼠踝关节滑膜病变,其作用机制可能与降低体内IL-1β、TNF-α水平有关。
Objective To explore the therapeutic effect and mechanism of shenjincao alkaloids(SJA) on arthritis induced by complete freund's adjuvant(CFA) in rats. Methods 48 healthy SD rats were randomly divided into 6 groups, 8 in each group,namely control group, model group, Etoncoxib(Positive drug, 1 mg/kg) group, and low-,medium-and high-dose(30, 60, and 120 mg/kg) SJA groups,40 healthy SD rats were injected with 0.1 mL CFA in addition to control group.The swelling rate of rat toes was measured and the pathological changes of ankle synovial membrane were observed.For 45 days, ELISA assay was used to determine the level of serum IL-1β and TNF-α. Results Compared with model group, the toe swelling rate of each group was significantly decreased(P < 0.05 and 0.01), and the levels of synovial cells, macrophages, fibroblast proliferation and inflammatory cell infiltration were also significantly decreased in medium and high doses of SJA groups. Compared with model group, the serum TNF-α level of rats in Etoncoxib and high-dose group of SJA decreased significantly(P < 0.05), and the IL-1β level of rats in Etoncoxib and each dose group of SJA decreased significantly(P < 0.01). Conclusion SJA can inhibit the CFA induced joint swelling in arthritis rats, improve ankle synovial lesions in rats, and have therapeutic effects on adjuvant arthritis rats. The mechanism may be related to decreasing the level of IL-1β and TNF-α in vivo.
引文
[1]蔡卓亚,周自桂,李萍,等.伸筋草化学成分及药理作用研究进展[J].中草药, 2015, 46(2):297-304.
[2] Blair H A, Deeks E D. Abatacept:a review in rheumatoid arthritis[J]. Drugs, 2017, 77(11):1221-1233.
[3]蔡卓亚,周自桂,李萍,等.伸筋草化学成分及药理作用研究进展[J].中草药, 2015, 46(2):297-304.
[3]吴晶金.类风湿关节炎动物模型研究进展[J].风湿病与关节炎, 2016, 5(12):70-73.
[4]韦婷,王天虹,曾勇,等.藏族药五味甘露药浴散加减方对佐剂关节炎大鼠药效血清NF-κB, TNF-α, IL-1,EGF的影响[J].中国实验方剂学杂志, 2016, 10(22):133-137.
[5]车萍,季旭明,梁粟,等.独活寄生汤对佐剂性关节炎大鼠的抗炎镇痛作用及血清中5-HTP, 5-HIAA的影响[J].中国实验方剂学杂志, 2014, 20(19):170-173.
[6]李艳杰,王丽娜.伸筋草配方颗粒的药理等效性实验研究[J].长春中医药大学学报, 2014, 30(3):403-404.
[7]敖鹏,周忠光,韩玉生.伸筋草氯仿提取物对佐剂性关节炎大鼠血清RF、TNF-α、IL-1、IL-6含量的影响[J].中医药信息, 2013, 30(3):129-131.
[8]张东军,边晓燕,尹丽颖.伸筋草乙醇提取物对佐剂性关节炎大鼠治疗作用的实验研究[J].中医药学报,2010, 38(4):41-42.
[9] Bustamante M F, Garcia-Carbonell R, Whisenant K D, et al. Fi-broblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis[J]. Arthritis Res Ther, 2017, 19(1):110.
[10]杨娟,左芳,魏志成,等.翼首草总苷对佐剂性关节炎大鼠药效及作用机制的研究[J].中药新药与临床药理,2016, 27(6):788-794.
